Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London (UCL), London, UK.
Priment Clinical Trials Unit. Research Department of Primary Care and Population Health, Universitty College London, London, UK.
Cochrane Database Syst Rev. 2024 Nov 19;11(11):CD016078. doi: 10.1002/14651858.CD016078.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primarily, to determine the effectiveness of a virtual reality (VR) intervention compared to an alternative or no intervention for people living with advanced cancer: on pain intensity, adverse events (AEs) and serious adverse events (SAEs); and secondarily, on additional pain properties (e.g. type, frequency), psychological well-being, other physical symptoms (e.g. anxiety) and quality of life. We will also report on the context in which the VR was implemented (setting, type and dose of VR).
这是一份 Cochrane 综述（干预措施）的方案。其目的如下：首先，比较虚拟现实（VR）干预与其他干预或不干预措施，评估其对晚期癌症患者的疼痛强度、不良反应（AE）和严重不良反应（SAE）的疗效；其次，评估 VR 对其他疼痛特征（如疼痛类型、频率）、心理幸福感、其他身体症状（如焦虑）和生活质量的影响。我们还将报告 VR 实施的背景（设置、VR 类型和剂量）。
